[vslist] ARVO 2004 SIG
Marilyn Schneck
mes@calmail.berkeley.edu
Tue Apr 13 20:33:09 2004
--============_-1130213157==_ma============
Content-Type: text/plain; charset="us-ascii" ; format="flowed"
ARVO 2004 SIG meeting, Wednesday April 28, 1:30-3:00 p.m. Room 114
Epidemiology of Visual Impairment: What's holding up the research?
Organizer: Gislin Dagnelie, PhD, JHU Lions Vision Center, Wilmer Eye
Institute, 550 N. Broadway, 6th fl., Baltimore, MD, 21205-2020.
Phone: 410-614-4822, Fax: 410-955-1829, E-mail: gdagnelie@jhmi.edu
Visual impairment research straddles many of the traditional
boundaries in ARVO. In addition to its traditional ties to
psychophysical and visual performance testing, the study of visual
impairment in the population should also have strong ties to
epidemiology and clinical research, to the study of (abnormal) visual
development, and to the study of visual outcomes in many areas of
ophthalmology. In this session, we want to combine the experiences
of researchers who have studied visual impairment and visual outcomes
in population-based studies with the expertise of specialists in the
organization of clinical trials, and those developing visual and
functional outcome measures, to address questions such as: How can
we improve the detection and treatment of visual impairment in the
population? What is required to validate (and increase) the efficacy
of vision rehabilitation programs? How can clinical trialists
contribute in studying the impact of visual impairment? What are
relevant functional outcome measures? Moderators: Gislin Dagnelie
and Robert Massof. Speakers: Marilyn Schneck, PhD, University of
California Berkeley; Maureen Maguire, PhD, University of
Pennsylvania; Susana Chung, PhD, University of Houston; Stanley Azen,
PhD, University of Southern California; Gerald McGwin, PhD,
University of Alabama Birmingham; Gary Rubin, PhD, University College
London; Robert Massof, PhD, Johns Hopkins University.
--
--============_-1130213157==_ma============
Content-Type: text/html; charset="us-ascii"
<!doctype html public "-//W3C//DTD W3 HTML//EN">
<html><head><style type="text/css"><!--
blockquote, dl, ul, ol, li { padding-top: 0 ; padding-bottom: 0 }
--></style><title>ARVO 2004 SIG</title></head><body>
<div><font face="Times New Roman" size="+1" color="#000000">ARVO 2004
SIG meeting, Wednesday April 28, 1:30-3:00 p.m. Room 114<br>
<br>
Epidemiology of Visual Impairment: What's holding up the research?<br>
<br>
Organizer: Gislin Dagnelie, PhD, JHU Lions Vision Center, Wilmer Eye
Institute, 550 N. Broadway, 6th fl., Baltimore, MD, 21205-2020. Phone:
410-614-4822, Fax: 410-955-1829, E-mail:<u> gdagnelie@jhmi.edu<br>
<br>
</u>Visual impairment research straddles many of the traditional
boundaries in ARVO. In addition to its traditional ties to
psychophysical and visual performance testing, the study of visual
impairment in the population should also have strong ties to
epidemiology and clinical research, to the study of (abnormal) visual
development, and to the study of visual outcomes in many areas of
ophthalmology. In this session, we want to combine the
experiences of researchers who have studied visual impairment and
visual outcomes in population-based studies with the expertise of
specialists in the organization of clinical trials, and those
developing visual and functional outcome measures, to address
questions such as: How can we improve the detection and
treatment of visual impairment in the population? What is
required to validate (and increase) the efficacy of vision
rehabilitation programs? How can clinical trialists contribute in
studying the impact of visual impairment? What are relevant
functional outcome measures? Moderators: Gislin Dagnelie and
Robert Massof. Speakers: Marilyn Schneck, PhD, University of
California Berkeley; Maureen Maguire, PhD, University of Pennsylvania;
Susana Chung, PhD, University of Houston; Stanley Azen, PhD,
University of Southern California; Gerald McGwin, PhD, University of
Alabama Birmingham; Gary Rubin, PhD, University College London; Robert
Massof, PhD, Johns Hopkins University.</font></div>
<div><br></div>
<x-sigsep><pre>--
</pre></x-sigsep>
</body>
</html>
--============_-1130213157==_ma============--